Humana Inc (NYSE:HUM)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $255.08, but opened at $267.91. Humana shares last traded at $280.19, with a volume of 2,338,947 shares trading hands.
Several research firms have recently weighed in on HUM. Zacks Investment Research cut shares of Hollysys Automation Technologies from a “hold” rating to a “sell” rating in a research note on Thursday, April 11th. Credit Suisse Group reaffirmed a “buy” rating and set a $19.50 price objective on shares of Infineon Technologies in a research report on Thursday, May 2nd. Barclays set a $24.00 price objective on shares of Tenet Healthcare and gave the stock a “hold” rating in a research report on Wednesday, April 17th. Morgan Stanley increased their price objective on shares of Zynga and gave the stock an “overweight” rating in a research report on Thursday, May 2nd. Finally, Oppenheimer lowered their price objective on shares of Littelfuse from $215.00 to $210.00 and set an “outperform” rating for the company in a research report on Thursday, May 2nd. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and fourteen have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $337.26.
The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $35.74 billion, a PE ratio of 19.26, a PEG ratio of 1.09 and a beta of 0.87. The company has a 50-day moving average of $258.06.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, May 1st. The insurance provider reported $4.48 earnings per share for the quarter, topping the Zacks’ consensus estimate of $4.30 by $0.18. The firm had revenue of $16.11 billion during the quarter, compared to analysts’ expectations of $15.67 billion. Humana had a net margin of 2.99% and a return on equity of 20.77%. The firm’s quarterly revenue was up 12.8% on a year-over-year basis. During the same quarter last year, the company posted $3.36 EPS. As a group, equities analysts forecast that Humana Inc will post 17.48 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a dividend of $0.55 per share. The ex-dividend date is Thursday, June 27th. This represents a $2.20 dividend on an annualized basis and a yield of 0.79%. Humana’s dividend payout ratio (DPR) is presently 15.12%.
A number of institutional investors have recently added to or reduced their stakes in HUM. Norges Bank acquired a new stake in Humana during the 4th quarter worth approximately $402,117,000. Millennium Management LLC lifted its holdings in Humana by 254.8% during the 4th quarter. Millennium Management LLC now owns 503,066 shares of the insurance provider’s stock worth $144,118,000 after buying an additional 361,263 shares in the last quarter. Ceredex Value Advisors LLC lifted its holdings in Humana by 31.8% during the 1st quarter. Ceredex Value Advisors LLC now owns 957,094 shares of the insurance provider’s stock worth $255,111,000 after buying an additional 230,671 shares in the last quarter. BlackRock Inc. lifted its holdings in Humana by 1.6% during the 1st quarter. BlackRock Inc. now owns 12,190,049 shares of the insurance provider’s stock worth $3,242,553,000 after buying an additional 186,997 shares in the last quarter. Finally, Calamos Advisors LLC lifted its holdings in Humana by 114.4% during the 1st quarter. Calamos Advisors LLC now owns 306,086 shares of the insurance provider’s stock worth $81,419,000 after buying an additional 163,339 shares in the last quarter. Institutional investors own 92.61% of the company’s stock.
About Humana (NYSE:HUM)
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Read More: Google Finance Portfolio Tips and Tricks
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.